Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an intensified treatment plus Rituximab
followed by autologous transplantation is superior to a conventional chemotherapy regimen
also supplemented with Rituximab.
Phase:
Phase 3
Details
Lead Sponsor:
Azienda Ospedaliera San Giovanni Battista
Collaborators:
Gruppo Italiano Studio Linfomi Gruppo Italiano Trapianto di Midollo Osseo Hoffmann-La Roche University of Turin, Italy